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Personalization and Precision: A New Paradigm
There is a sense of excitement and change occurring in
mainstream medicine. President Obama, in his State of the
Union address on January 30, 2015, announced a national
Precision Medicine Initiative (The White House 2015).
More recently, the United Kingdom’s government inno-
vation agency started a Precision Medicine Catapult
designed to enhance the development of precision medi-
cine in the UK (Precision Medicine Catapult 2015). Pre-
cision medicine is defined by the National Research
Council as ‘‘the tailoring of medical treatment to the
individual characteristics of each patient’’ (National
Research Council (US) Committee on A Framework for
Developing a New Taxonomy of Disease 2011). This
builds on an increasing interest in personalized medicine
and, indeed, the terms ‘‘precision medicine’’ and ‘‘per-
sonalized medicine’’ are sometimes used interchangeably
(Avitabile 2015). Common to both is an emphasis on
tailoring treatment to individual needs and, increasingly, on
the role of technology to support that goal (Carney 2014;
Sacchi et al. 2015).
Although much of the focus of medicine to date has
been on biomarkers and genetics (McCarty et al. 2011), the
concept is not limited to those factors. Just as critical, but
less widely elaborated, are psychosocial variables that also
fit under the umbrella of precision and personalized med-
icine. Increasing discussion has also focused on the rele-
vance of precision medicine to mental health. Thomas
Insel, a former Director of the National Institute of Mental
Health (NIMH), has argued that the basic tenets of preci-
sion medicine are reflected in the NIMH Research Domain
Criteria (RDoC) project, ‘‘which aims to develop more
precise diagnostic categories based on biological, psycho-
logical, and socio-cultural variables’’ (Insel 2015). He adds
that
‘‘…precision medicine for mental disorders will not
come from a single genomic glitch. Rather, like
many other areas of medicine, many genes each
contribute only a small amount of vulnerability as
part of an overall risk profile that includes life
experiences, neurodevelopment, and social and cul-
tural factors. RDoC assumes that we will need many
kinds of data to reach precision, more like triangu-
lating to find your position on a map. These data
will draw from many sources, including symptoms,
genotype, physiology, cognitive assessment, family
dynamics, environmental exposures, and cultural
background.’’
The NIMH’s emphasis on including a wide variety of
assessment data in the pursuit of precision recognizes that
mental health must move beyond genetic factors as the sole
focus of RDoC-facilitated precision.
Authors contributed equally and are listed alphabetically
& Miranda Wolpert
Miranda.Wolpert@annafreud.org
1 Vanderbilt University, Nashville, TN, USA
2 Department of Psychiatry and Behavioral Sciences,
University of Washington, 6200 NE 74th St., Suite 100,
Seattle, WA 98115, USA
3 Evidence Based Practice Unit, UCL and the Anna Freud
Centre, 12 Maresfield Gardens, London NW3 5SU, UK
123
Adm Policy Ment Health
DOI 10.1007/s10488-016-0718-5
Precision Mental Health: Definitions
and Requirements
For precision medicine to become a reality in mental
health, it is necessary to have precise assessment, moni-
toring, and feedback information. We define precision
mental health as an approach to prevention and interven-
tion that focuses on obtaining an accurate understanding of
the needs, preferences, and prognostic possibilities for any
given individual, based on close attention to initial
assessment, ongoing monitoring, and individualized feed-
back information, and which tailors interventions and
support accordingly in line with the most up-to-date sci-
entific evidence. In particular, this data-driven approach to
clinical decision-making should include seven types of
psychosocial data, which are described below (and sum-
marized in Table 1):
(1) Personal data relevant to understanding the nature
of presenting problems and how they might be
addressed may include description of the presenting
problem and/or psychiatric diagnoses, but also
consideration of other factors, including genetic,
developmental, social, and cultural variables. We
anticipate that this will go beyond more than just
symptoms, to include prominent and systematic
consideration of information that may inform inter-
vention choices, including motivation to change,
personality traits, and demographics.
(2) Aims and risks data Clarifying the focus and
expected outcomes of treatment as well as any risks
or likely side effects is a key issue for mental health
and one that currently is all too often hazy or ill-
defined. This does not mean that service users get to
choose any aim or goal to work on and the service
provider has to comply; rather, this is about captur-
ing what has been mutually agreed as the focus for
treatment to allow precision in terms of tailoring the
intervention to the aim, along with any acknowl-
edged risks, and ensuring progress toward this end.
Service recipients with identical symptom profiles
and case formulations often have different aims, and
these aims may further diverge from those of their
care provider. Precision mental health tailors activity
to the specific agreed-upon aims.
(3) Service preference data relevant to understanding
patient/client choices at key decision points regard-
ing services. Similar to aims data, service recipients
with identical symptom profiles and case formula-
tions may have divergent preferences for different
interventions. In situations where the evidence for
two different interventions is relatively equally
balanced, then preference data are crucial to help
guide intervention selection, to ensure personaliza-
tion and precision (Jacob et al. 2015), and to prevent
misdiagnosis of preference (Mulley et al. 2012).
(4) Intervention data that capture aspects of the services
delivered over the course of treatment, including
their dose/intensity, duration, cost, and timing. This
includes precision as to different interventions and
aspects of interventions, and may benefit from
taxonomies that are not just modality based, using
the TIDieR framework to capture details of inter-
ventions (Hoffmann et al. 2014). These include the
behavioral taxonomy developed by Michie et al.
(2014) and the ‘‘common elements’’ of evidence-
based treatments suggested by Chorpita et al. (2005),
alongside more traditional ‘‘common factors’’ iden-
tified in the literature (Bickman 2005). Aspects of
intervention integrity/fidelity (i.e., adherence, com-
petence, differentiation, and relational elements;
Southam-Gerow and McLeod 2013) also represent
key aspects of intervention data.
(5) Progress data relevant to understanding movement
toward the intended and agreed aims of any inter-
vention and against identified benchmarks (see #3
above). These data are collected routinely over time
using within-subjects comparisons and relevant
metrics as identified in #1 and #3 above.
(6) Mechanisms data relevant to the hypothesized link
between intervention and outcomes (Kazdin, 2007).
These are frequently the hypothesized mediators of
Table 1 Types of psychosocial data relevant to precision mental
health
Data type Description
Personal data Individual-level information that may inform
intervention choice/selection (e.g.,
demographics; diagnoses; cultural variables;
motivation to change)
Aims and risks
data
The focus and expected outcomes of treatment as
well as potential risks
Services
preference data
Client choices/selections at key decision points
regarding services
Intervention data Aspects of the services delivered over the course
of treatment (e.g., intervention integrity; dose/
intensity; duration; timing)
Progress data Movement toward the intended and agreed aims
of any intervention, and against identified
benchmarks
Mechanisms data The hypothesized link between intervention and
outcomes. May be mediators of treatment (e.g.,
skills development or use, therapeutic alliance,
etc.)
Contextual data Factors external to the individual/intervention
that moderate or mediate outcomes (e.g.,
quality and amount of service available; family
functioning data)
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treatment. For example, therapeutic alliance would
be included as an explanatory factor if it is not
considered to be an explicit component of the
intervention (see #5), but this might also include
skills developed by the service recipient as part of
the intervention, such as increased coping skills or
social skills.
(7) Contextual data relevant to understanding the factors
that moderate or mediate outcomes, such as quality
and amount of service available, or other data
external to the individual or the intervention deliv-
ered (which are captured in #4 and #6). These are
data about the environment in which the individual
lives, in contrast to personal data (described in #1).
Precision mental health can be distinguished from cur-
rent ‘‘best practice’’ in mental health promotion and pro-
vision in the following ways. First, it involves careful,
ongoing consideration of the seven data elements above
over the course of any intervention. In this way, precision
mental health should be ‘‘data driven’’ in a manner that
extends well beyond the growing contemporary emphasis
on client outcome tracking. Second, given the extensive
data that will be required to make precision mental health a
reality, our conceptualization is committed to using rele-
vant technology to manage information and support pre-
cision in assessment monitoring and feedback. It should be
acknowledged, however, that precision mental health is
currently an aspirational goal and that much of the current
data in mental health are largely flawed and proximate
(Wolpert et al., 2014). In light of this, those seeking to
support precision mental health need to take due account of
the imprecision of current data sources.
Precision Mental Health, Measurement,
and Feedback in Clinical Practice
This special issue marks a step toward considering current
best practice in using these data sources to support preci-
sion mental health across both the United States and the
United Kingdom. Although none of the authors in the
present issue have conceptualized their work in terms of
precision mental health, we feel that all the contributors are
working toward this end. We advocate that, as a commu-
nity of researchers and practitioners, we should begin to
frame the collection and use of patient-reported outcomes
and other measures in terms of precision mental health. We
anticipate that doing so will not only facilitate alignment
between mental health and the broader healthcare agenda,
but also help to overcome some terminology differences
that have emerged in the areas of outcome monitoring and
feedback, which we would like to redress.
In particular, there is a plethora of terms used across the
literature to refer to various components of precision
mental health services. These include Measurement-Based
Care (MBC) (Scott and Lewis 2015), Outcome-Informed
Therapy (Duncan et al. 2011), Feedback Informed Therapy
(FIT) (Miller et al. 2015), Routine Outcome Monitoring
(ROM) (Carlier et al. 2012), and Measurement Feedback
Systems (MFS) (Bickman 2008). Among these, ROM and
MFS are the two most common shorthand terms that have
come to be used differently across the United States and
United Kingdom to refer to the varied elements of the
assessment, monitoring, and feedback process. The former
emphasizes the importance of collecting data that inform
an understanding of outcomes—with a focus particularly
on #1–3 and 5 above—and is widely used in the United
Kingdom. The latter emphasizes the use of systems to
provide feedback from those accessing services, which also
focuses on data related to #1–3 and 5 above, but has
additionally paid more attention to other relevant data on a
routine basis, including mechanism data (#6 above), and
consideration of the nature of interventions (#4 above).
This includes natural language descriptions of the content
of treatment above (Kelly et al. this issue) and specific
evidence-based intervention components (Chorpita et al.
this issue). In practice, the terms are often used inter-
changeably, and those promoting ROM and MFS approa-
ches share a common commitment to systematically
capturing data and supporting clinicians to make use of all
the elements listed above. Regardless of the terminology,
this is a revolutionary perspective given that traditional
mental health intervention does not involve any systematic
data collection or considerations of outcomes from the user
perspective (Garland et al. 2003; Hatfield and Ogles 2004).
Moreover, these are universal approaches to improving
outcomes that can be used regardless of the type of treat-
ment or characteristics of the client or clinician. We would
advocate that they be increasingly subsumed under the
term precision mental health.
Precision Mental Health: Challenges
and Opportunities
Relevant Data Components
We anticipate that the advancement of precision mental
health will require greater use of data sources not yet fully
tapped by current approaches to mental health symptom
assessment, such as educational- or employment-related
functioning, cognitive and neurological testing, and other
bio-social indicators (relevant to #1, 6, and 7 above). There
is no conceptual reason why these data elements cannot be
increasingly integrated into feedback systems, particularly
Adm Policy Ment Health
123
as systems move to be largely digital and cloud-based with
rapid real-time reporting possible (Lyon et al. 2016).
However, since many of the measures developed in this
area are laboratory-derived, a translational process might
be necessary to make them feasible in the real world. For
example, Bickman and colleagues developed a battery of
measures that are designed for use in real-world settings
where time is short (Bickman and Athay 2012).
Moreover, precision mental health provides an opportu-
nity for the field to move beyond traditional self-report data.
Almost all the data currently collected are based on clients’
or others’ completion of questionnaires. Although such an
approach provides critical information about clients’ per-
ceptions of their own difficulties, this mono-method
dependency is problematic. While we are aware that we still
have much work to do to integrate and understand self-
report data (De Los Reyes 2011), we are missing new and
rapidly emerging sources of information. For instance,
Torous and Baker (2016), as well as many others, have
noted that the new technologies based on smartphones and
wearable sensors offer access to data and events that are not
possible with electronic or paper-based questionnaires
completed in the office or clinic. Although there are
numerous complex issues that need to be resolved with the
use of these new technologies (e.g., privacy, security,
validity), there is significant potential to transform what we
know about mental health and mental health services.
Among the data sources captured in the list presented
above, information about the intervention itself (#4 above)
is particularly underdeveloped. Physical medicine is going
through a major cultural shift from the practice of medicine
as an art to medicine that is evidence based and follows
guidelines and standards. However, this has not been a
simple journey, and some of the problems encountered may
be remedied by an emphasis on precision medicine
(Greenhalgh et al. 2014). Although many evidence-based
treatments exist in mental health, research indicates that
these are not yet part of the mainstream clinical culture
(Becker et al. 2013). Moreover, there is currently little
incentive for providers to use these treatments and monitor
their fidelity. Thus, most care is described using the
imprecise—and typically heterogeneous—term ‘‘treatment
as usual’’. Many of the feedback studies to date have
introduced feedback practices into that ‘‘treatment as
usual’’ context, which may not be optimal. This lack of
precision in describing treatment is a handicap for feedback
systems, because is it unclear not only what data to relay,
but also what actions the clinician should take based on the
feedback. The use of frameworks to identify intervention
components (e.g., Chorpita et al. 2005; Michie et al. 2014)
should continue to be advanced, but they are not yet widely
embedded in practice, as will be noted in many of the
contributions to this special issue.
Building Precision Mental Health Databases
The mental health field lacks high-quality, large databases
that include linked data from #1 to #7 above. Databases
currently available to form the basis for precision medicine
are likely to be drawn from three sources: clinical trials,
routine care, and cohort studies. While we could find no
systematic data on the sizes of clinical trials, ClinicalTri-
als.gov, as of December 2015, lists 192,475 trials, 7366
(3.8 %) of which deal with some aspect of mental health.
Most of these include some elements of #1–7, but not all.
Furthermore, many will be limited in the populations
covered. Cohort studies including those developed by
groups of volunteers are a potentially useful source of data
(Precision Medicine Initiative Working Group, 2015), but
the mental health aspects of such databases are typically
limited. For the foreseeable future, routine care is likely to
be the key source of data for pursuing precision mental
health. However, these datasets are likely to be highly
flawed and incomplete, suffering from the challenges
common to administrative datasets (e.g., missingness,
inadequate specification) and exacerbated by the fact that,
in mental health, we will have to depend on typical com-
munity-based treatment. Significant sources of data for
health care are hospital data systems and laboratory test
results. Hospitals and laboratories have a long history of
collecting and maintaining relatively high-quality data, but
outpatient mental health services often do not share this
tradition. Furthermore, most existing data systems are not
designed to ‘‘talk’’ to each other. This interoperability
problem exists in physical medicine, but there are financial
incentives for providers to develop such systems (e.g.,
Blumenthal and Tavenner 2010). Moreover, there are large
investments being made by governments to create
solutions.
Presently, ROM and MFS are in the forefront of
developing technologies suitable for mental health to
obtain the needed data. However, given the lack of similar
incentives and financial resources, and the lack of stan-
dardized and widespread measurement, progress will be
slow. The quality of mental health data from routinely
collected data sources is therefore likely to remain a
problem for some time to come. Many of the papers in this
special issue deal with the problems inherent in collecting
such data in the real world.
Facilitating Ease of Data Capture and Use in Mental
Health
One of the major challenges this field faces concerns the
implementation of data capture and use in the context of
under-resourced and overstretched services. In many cases,
new measures must be developed because the existing
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measures were developed for research projects without
severe time restrictions for data collection. The resources
available in research settings stand in contrast to the con-
ditions of service delivery in the real world, where
assessment is often seen as ‘‘stealing’’ time from treatment.
Furthermore, the focus on monitoring makes more relevant
individualized (i.e., idiographic) assessment approaches
that are typically used for intra-individual comparisons
(i.e., comparing individuals with themselves over time),
rather than comparing individuals with established norms
from a larger population (Haynes et al. 2009; Weisz et al.
2011). Many of the articles in this issue address the issue of
implementation and draw on implementation science for
suggested ways forward.
MFS and ROM Support Precision Mental Health
The current special issue contains two companion sections
that showcase projects designed to support the elements of
precision mental health listed above. They address some
of the challenges previously identified via different tech-
nical (i.e., training, consultation, learning collaborative)
and technological (i.e., digital measurement feedback
systems and electronic health records) strategies. The
special issue arose because of a range of work going on
across the United States, United Kingdom, and elsewhere
(e.g., the Netherlands) where researchers and practitioners
were experiencing common challenges and concerns.
Originally designed as two separate contributions, the
commonalities between the groups became clear and
therefore they were brought together in one issue while
treating each section with its own introduction and over-
view. For specific information about the individual article
author contributions, the reader is referred to the individ-
ual special section introductory papers. Specifically,
Edbrooke-Childs, Wolpert and Deighton (this issue) have
prepared a section focused on the use of patient-reported
outcome measures (PROMs), which includes considera-
tion of training and support necessary to allow for
implementation. Lyon and Lewis (this issue) oversee a
section that focuses on the development and implemen-
tation of digital MFS technologies explicitly designed to
support ROM practice.
Papers in both sections stress that implementation and
long-term sustainment of using patient-reported outcomes
and other data to inform practice can be fraught with
challenges, such as varying levels of organizational buy-in,
long timelines, and mounting costs. Nevertheless, they also
demonstrate the potential payoffs of successfully installing
these innovations. Furthermore, the papers make it clear
that the implementation of feedback technologies involves
many of the same issues as those involved in the imple-
mentation of other evidence-based practice changes in
behavioral health. Thus, they require good design and
packaging to make them accessible and useable for prac-
titioners, and to facilitate their uptake and long-term use.
This may be accomplished by explicitly incorporating
stakeholders and stakeholder perspectives into structured
processes for the development, selection, and implemen-
tation of new innovations. Consistent with the broader
implementation literature (Beidas and Kendall 2010),
effective training and consultation procedures are neces-
sary regardless of the type of innovation being imple-
mented. Furthermore, both sections make clear the value of
qualitative, quantitative, and mixed-methods approaches to
(1) evaluate clinician and service recipient views toward
the technological and practice changes that characterize
implementation of feedback approaches, (2) tailor the
practices or technologies to meet their needs, and (3)
determine their effectiveness in promoting positive service
outcomes. With this special issue, we hope to advance the
science and practice of precision mental health by con-
sidering the capture, feedback, and use of data in com-
munity service settings, as well as the processes and
strategies through which these innovations are developed,
implemented, and evaluated.
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